Evidence map›Paper›PMID 38674086›Full record

ArticleInternational journal of molecular sciences2024

Human T-Cell Responses to Metallic Ion-Doped Bioactive Glasses.

Hugo Abreu, Mari Lallukka, Marta Miola, Silvia Spriano, Enrica Vernè, Davide Raineri, Massimiliano Leigheb, Mario Ronga, Giuseppe Cappellano, Annalisa Chiocchetti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hugo AbreuDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-4720-6519
Mari LallukkaApplied Science and Technology Department, Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0001-8360-7665
Marta MiolaApplied Science and Technology Department, Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0002-1440-6146
Silvia SprianoApplied Science and Technology Department, Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0002-7367-9777
Enrica VernèApplied Science and Technology Department, Politecnico di Torino, 10129 Torino, Italy.ORCID 0000-0002-8649-4739
Davide RaineriDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0003-3327-6305
Massimiliano LeighebDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.
Mario RongaDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.
Giuseppe CappellanoDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0001-5193-4688
Annalisa ChiocchettiDepartment of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-4349-1087
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITPolitecnico di Torino · IT

Funding

European Union's Horizon 2020 860462European Union's Horizon 2020 953121MIUR PNNR ECS00000036
6 · The paper itself

Abstract

Biomaterials are extensively used as replacements for damaged tissue with bioactive glasses standing out as bone substitutes for their intrinsic osteogenic properties. However, biomaterial implantation has the following risks: the development of implant-associated infections and adverse immune responses. Thus, incorporating metallic ions with known antimicrobial properties can prevent infection, but should also modulate the immune response. Therefore, we selected silver, copper and tellurium as doping for bioactive glasses and evaluated the immunophenotype and cytokine profile of human T-cells cultured on top of these discs. Results showed that silver significantly decreased cell viability, copper increased the T helper (Th)-1 cell percentage while decreasing that of Th17, while tellurium did not affect either cell viability or immune response, as evaluated via multiparametric flow cytometry. Multiplex cytokines assay showed that IL-5 levels were decreased in the copper-doped discs, compared with its undoped control, while IL-10 tended to be lower in the doped glass, compared with the control (plastic) while undoped condition showed lower expression of IL-13 and increased MCP-1 and MIP-1β secretion. Overall, we hypothesized that the Th1/Th17 shift, and specific cytokine expression indicated that T-cells might cross-activate other cell types, potentially macrophages and eosinophils, in response to the scaffolds.

Indexed as

CytokinesGlassBiocompatible MaterialsCells, CulturedCell SurvivalCopperHumansIonsMetalsTh17 CellsTh1 CellsT-LymphocytesBiocompatible MaterialsCopperCytokinesIonsMetalsbioactive glassesimmunobiocompatibilityinflammationmetallic ion dopingmultiparametric flow cytometrytissue regeneration

Identifiers

PMID38674086
PMCPMC11050560
OpenAlexW4394963558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.